Tag: fda

7 takeaways from FDA hearing on CBD and hemp

7 takeaways from FDA hearing on CBD and hemp

June 9, 2019 |

In Washington, D.C., last week, the Food and Drug Administration held a public hearing to determine a pathway toward regulating CBD. Mile High Labs Founder and CTO, Stephen Mueller spoke at this hearing and provided 7 recommendations to the FDA. He said “Don’t wait to regulate. CBD is rapidly becoming a preferred ingredient in everything […]

Read More

FDA approves Brazilian GMO sugarcane

FDA approves Brazilian GMO sugarcane

August 13, 2018 |

In Washington, the Food and Drug Administration (FDA) concluded recently that raw and refined sugar produced from Brazil’s first genetically-modified sugarcane variety, called CTC20BT and developed by the CTC, is safe. The US FDA focused its safety assessment on sugar because it is the main sugarcane-derived product imported to the US from Brazil. In addition to […]

Read More

Certification Program Launched to Help Biodiesel Producers Meet FSMA Requirements

Certification Program Launched to Help Biodiesel Producers Meet FSMA Requirements

April 22, 2018 |

In Iowa, the Iowa Biodiesel Board developed a biodiesel Food Safety Program to help producers get into compliance with the new requirements for food-grade ingredients. Biodiesel producers who want to sell glycerin that can end up as an animal food ingredient will soon be up against the deadline to comply with new government regulations. The […]

Read More

US Senator wants DDGs removed from proposed FDA rule

US Senator wants DDGs removed from proposed FDA rule

April 21, 2014 |

In Washington, U.S. Sen. Mike Johanns (R-Neb) wrote Food and Drug Administration (FDA) Commissioner Margaret Hamburg urging FDA to exempt raw agricultural commodities, distillers grain and other byproducts from a promised revision of a proposed rule dealing with livestock feed. As first proposed, the rule would add new requirements to producers of distillers grains – […]

Read More

FDA has sent Star Scientific a warning letter regarding consumer products

FDA has sent Star Scientific a warning letter regarding consumer products

January 2, 2014 |

In Virginia, Star Scientific announced the receipt on December 24, of a warning letter from the U.S. Food and Drug Administration regarding two consumer products, Anatabloc and CigRx, which are marketed by Star. Both the consumer products contain anatabine, a substance naturally occurring in various plants. In the letter, the agency asserts that anatabine is […]

Read More

Missouri project to heighten oleic acid content in soybeans

Missouri project to heighten oleic acid content in soybeans

November 18, 2013 |

In Missouri, a research effort to increase the amount of oleic acid found in soybean oil is already underway after the FDA announced its conclusion that trans fats are unsafe in food at the University of Missouri. Developing high oleic acid content traits in soybeans would avoid genetically modifying the beans, and could benefit the […]

Read More

FDA approves Arundo donax, Chemtex plant gets green light

FDA approves Arundo donax, Chemtex plant gets green light

July 8, 2013 |

In North Carolina, the FDA has signed off on the use of Arundo donax as a biofuel crop, which is the crop utilized by a $200 million Chemtex plant expected to be operational by mid-2015. The feedstock, which will be used to create cellulosic fuel, is a perennial cane that is prized for its fast […]

Read More

FDA warns against toxic chemicals in jatropha-based glycerin.

FDA warns against toxic chemicals in jatropha-based glycerin.

July 10, 2012 |

In Washington, the FDA is warning glycerin users in the pharmaceuticals industry to make sure that the glycerin’s origins aren’t from jatropha because they may contain toxic chemicals such as phorbol esters that may not be picked up in standard purity tests.

Read More

US House reps question antibiotic use in ethanol production

US House reps question antibiotic use in ethanol production

May 15, 2012 |

In Washington, Representatives Edward J. Markey (D-Mass.) and Louise Slaughter (D-N.Y.) have written to the Food and Drug Administration (FDA) to ask hard questions about whether the agency is doing its job to protect the public in addressing the issue of antibiotic use in ethanol. Reps. Markey and Slaughter, in their letter to the FDA, […]

Read More

FDA approves Codexis enzyme for Merck

FDA approves Codexis enzyme for Merck

April 30, 2012 |

In California, the FDA has approved Codexis’ new process for the manufacture of sitagliptin, the active ingredient in Merck’s new drug Januvia. The approved process, which won the Presidential Green Chemistry Award in 2010, is a more environmentally friendly and efficient production process than those used in the past. Specifically, it indicates the potential for improving […]

Read More